Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2025-12-25 @ 2:38 PM
NCT ID: NCT03428750
Description: All (serious and nonserious) AEs, whether elicited or observed during study visits or spontaneously reported by the participant, including events that occurred from the time the participant signed the study-specific consent form until completion of or discharge from the study.
Frequency Threshold: 5
Time Frame: All (serious and nonserious) AEs, from Day 1 to Day 71
Study: NCT03428750
Study Brief: Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Collagenase Clostridium Histolyticum (CCH) CCH 0.84 mg/Buttock 1.68 mg Total Dose 0 None 0 210 166 210 View
Placebo Placebo-control 0 None 1 213 55 213 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Colitis ischaemic SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site bruising SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection stie nodule SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site pruritus SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site haemorrhage SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site mass SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Injection site discolouration SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View